Abstract
Intravesical instillation of epirubicin (EPI) is one of the most effective adjuvant therapies for nonmuscle-invasive bladder cancer postoperation. We evaluated the long-term efficacy of single dose intravesical epirubicin for superficial bladder carcinoma recurrence. Between June 1997 and May 1998, a total of 47 patients with resectable superficial bladder carcinoma (Ta-1, Grade 1-2), primary or recurrent with no recurrence during last one year, were enrolled in this study. All patients were randomized into 3 study groups: Group A-single epirubicin (80 mg/40 mL of normal saline) was administered into the bladder within 6 hours postoperation; Group B-40 mg Epirubicin consecutively; Group C-40 mg mitomycin C, consecutively. In Group B and C, instillation were given every week for 6- 8 weeks and then every one month for 10 months. Patients were followed up at 3, 6, 9, 12, 18, 24, 36, 48, and 60 months of treatment. The analyzed background factors were the therapeutic method, tumor recurrence, and side effects. Of the 47 patients, 43 (91.5 percent) were eligible and were followed up for 5 years postoperation. The disease free intervals of the three groups were found to have no significant differences (F = 10.28, p > 0.05). The recu...Continue Reading
References
Nov 3, 1991·The New England Journal of Medicine·D L LammM F Sarosdy
Aug 1, 1989·The Journal of Urology·M K ParmarD A Tolley
Apr 1, 1993·The Journal of Urology·W OosterlinckR Sylvester
Apr 1, 1996·The Journal of Urology·D A TolleyP Whelan
May 1, 1997·British Journal of Urology·B Ali-el-DeinA Ashamallah
Apr 29, 1998·European Urology·K OkamuraS Ohshima
Sep 8, 1998·Urology·J A WitjesW P Witjes
Mar 19, 1999·The Journal of Urology·E SolsonaR Dumont
Mar 19, 1999·The Journal of Urology·P RajalaO Lukkarinen
May 5, 1999·International Journal of Urology : Official Journal of the Japanese Urological Association·T KondoH Toma
May 23, 2002·Journal of Chemotherapy·N K MohantyR P Arora
Oct 3, 2002·Cancer Chemotherapy and Pharmacology·Koichiro NomataUNKNOWN Nagasaki Clinical Research Group for Bladder Cancer
Jan 22, 2003·International Journal of Urology : Official Journal of the Japanese Urological Association·Isao HaraUNKNOWN Kobe Urogenital Tumor Study Group
Jun 11, 2003·The Journal of Urology·Derek A HausladenRobert M Weiss
Jan 12, 2005·The Journal of Urology·Theo M de ReijkeUNKNOWN European Organization for the Research and Treatment of Cancer-Genito-Urinary Group
Citations
Mar 29, 2008·Pharmaceutical Research·Zancong ShenJessie L-S Au
Jan 19, 2010·Expert Opinion on Investigational Drugs·Marc C SmaldoneJeffrey R Gingrich
Jan 22, 2008·European Urology·Richard J SylvesterJ Alfred Witjes
Apr 9, 2008·Current Opinion in Oncology·Daniel A Barocas, Peter E Clark
Nov 30, 2010·World Journal of Urology·Alon Z WeizerJeffrey S Montgomery
Sep 1, 2015·Integrative Cancer Therapies·Liansheng RenJing Wang
Jul 12, 2019·Military Medicine·Joseph M CaputoChristopher B Anderson